Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.71 - $2.43 $75,913 - $259,815
-106,920 Closed
0 $0
Q1 2022

May 04, 2022

SELL
$2.31 - $5.13 $36,036 - $80,028
-15,600 Reduced 12.73%
106,920 $255,000
Q4 2021

Feb 14, 2022

BUY
$4.45 - $8.09 $84,505 - $153,629
18,990 Added 18.34%
122,520 $584,000
Q3 2021

Nov 08, 2021

SELL
$6.94 - $8.85 $2,012 - $2,566
-290 Reduced 0.28%
103,530 $810,000
Q2 2021

Aug 09, 2021

BUY
$7.45 - $16.27 $773,459 - $1.69 Million
103,820 New
103,820 $837,000

About CURIS INC


  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.